CD22 and spondylo-ocular syndrome: Drug-induced liver injury and SOS are well-documented with InO therapy, and postulated to be due to non-specific uptake of InO by liver sinusoidal endothelial cells (SECs) given the lack of CD22 expression within the normal liver (36).